D
TriSalus Life Sciences, Inc. TLSI
$5.10 $0.173.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 52.27% 41.97% 44.40% 41.52% 59.67%
Total Other Revenue -- -- -- -- --
Total Revenue 52.27% 41.97% 44.40% 41.52% 59.67%
Cost of Revenue 97.59% 53.96% 108.93% 70.46% 18.13%
Gross Profit 45.86% 39.85% 37.09% 37.81% 68.02%
SG&A Expenses 28.71% 3.46% 15.14% -2.81% 18.74%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 19.35% -9.01% -12.07% -26.36% -3.17%
Operating Income 10.30% 37.21% 34.70% 51.03% 28.51%
Income Before Tax -91.70% 21.46% 71.63% -68.56% 69.02%
Income Tax Expenses -142.86% 66.67% -200.00% -- -46.15%
Earnings from Continuing Operations -91.32% 21.44% 71.64% -68.35% 69.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -91.32% 21.44% 71.64% -68.35% 69.00%
EBIT 10.30% 37.21% 34.70% 51.03% 28.51%
EBITDA 10.19% 37.75% 35.17% 51.69% 29.28%
EPS Basic -27.43% 35.30% 74.80% 15.47% 99.40%
Normalized Basic EPS 63.74% 15.27% 64.33% 91.18% 97.69%
EPS Diluted -27.43% 35.30% 74.80% 15.47% 99.40%
Normalized Diluted EPS 63.74% 15.27% 64.33% 91.18% 97.69%
Average Basic Shares Outstanding 37.63% 22.31% 18.59% 101.18% 5,255.97%
Average Diluted Shares Outstanding 37.63% 22.31% 18.59% 101.18% 5,255.97%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --